← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $5.2M of United Therapeutics Corporation

Sold$5,215,015
$548.95Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Oct 8Copier in Oct 9
The stock from Fri, Oct 9 open, $528.92
+2.7%
S&P 500, same days
−1.3%

6 of 30 trading days so far, to the Oct 19 close.

Traded Wed, Oct 7. Filed Thu, Oct 8, 5:28 PM ET, after the close. Returns use the Oct 9 open and the Oct 19 close. Not investment advice.